FIGURE 4.

Change in SBP over 24 h recorded by ABPM. Change in SBP as recording by ABPM in patients treated with placebo (n = 16) (a), finerenone 10 mg (n = 17) (b), finerenone 15 mg (n = 24) (c), and finerenone 20 mg (n = 18) (d). Mean SBP at hourly intervals demonstrated a similar pattern in SBP across treatment groups at screening, with lower nocturnal than daytime SBP. Reduction in SBP with finerenone at Day 90 was persistent across all time points and was generally below that of the mean screening values. ABPM, ambulatory blood pressure monitoring; SBP, systolic blood pressure; SE, standard error.